Search Results - "Valk, Harold W."

Refine Results
  1. 1

    Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis by de Vries, Marieke, Westerink, Jan, Kaasjager, Karin H A H, de Valk, Harold W

    “…Abstract Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients with obesity and type 2 diabetes, and is expected to rise…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mortality patterns in Dutch diabetes outpatients by Bak, Jessica C. G., Vries, Silvia A. G., Serné, Erik H., Groenwold, Rolf H. H., Valk, Harold W., Mul, Dick, Sas, Theo C. J., Bizino, Maurice, Nieuwdorp, Max, Kramer, Mark H. H., Verheugt, Carianne L.

    Published in Diabetes, obesity & metabolism (01-10-2024)
    “…Aim Diabetes mellitus is a major cause of death. Outpatients with diabetes have more complications than patients in general practice; mortality patterns have…”
    Get full text
    Journal Article
  4. 4

    Needle Technology for Insulin Administration: A Century of Innovation by Heinemann, Lutz, Nguyen, Trung, Bailey, Timothy S., Hassoun, Ahmed, Kulzer, Bernd, Oliveria, Teresa, Reznik, Yves, de Valk, Harold W., Mader, Julia K.

    Published in Journal of Diabetes Science and Technology (01-03-2023)
    “…Innovations in syringe and pen needle (PN) technology over the last 100 years have led to important advances in insulin delivery for people with diabetes,…”
    Get full text
    Book Review Journal Article
  5. 5

    Gender gaps in type 1 diabetes care by Bak, Jessica C. G., Serné, Erik H., de Valk, Harold W., Valk, Niek K., Kramer, Mark H. H., Nieuwdorp, Max, Verheugt, Carianne L.

    Published in Acta diabetologica (01-03-2023)
    “…Aims Diabetes mellitus is one of the largest global health concerns of recent times. Women with diabetes mellitus have a higher excess risk of all-cause…”
    Get full text
    Journal Article
  6. 6

    The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort by Oppelaar, Lisa M., Luijk, Bart, Heijerman, Harry G.M., De Valk, Harold W., van Meerkerk, Gerdien Belle

    Published in Clinics (São Paulo, Brazil) (01-01-2023)
    “…•Cystic fibrosis related vascular complications.•Survival of people with cystic fibrosis.•Cystic fibrosis related vascular complications and metabolic…”
    Get full text
    Journal Article
  7. 7

    Is the evidence strong enough to change the diagnostic criteria for gestational diabetes now? by Visser, Gerard H.A., MD, PhD, de Valk, Harold W., MD, PhD

    “…The International Association of the Diabetes and Pregnancy Study Groups has proposed new thresholds for oral glucose tolerance tests that are based on the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review by Bos, Dieuwke C, de Ranitz-Greven, Wendela L, de Valk, Harold W

    Published in Diabetes technology & therapeutics (01-07-2011)
    “…Advanced glycation end products (AGEs) are long-lived tissue proteins that accumulate in diabetes. Skin AGEs measured in biopsy specimens strongly correlated…”
    Get more information
    Journal Article
  10. 10

    Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands – study protocol by Jancev, Milena, Snoek, Frank J, Frederix, Geert W J, Knottnerus, Heleen, Blauw, Helga, Witkop, Maureen, Moons, Karel G M, van Bon, Arianne C, DeVries, J Hans, Serné, Erik H, van Sloten, Thomas T, de Valk, Harold W

    Published in BMJ open (23-08-2023)
    “…IntroductionThe management of type 1 diabetes (T1DM) has undergone significant advancements with the availability of novel technologies, notably continuous and…”
    Get full text
    Journal Article
  11. 11

    Effects of COVID-19 on diabetes care among dutch diabetes outpatients by Bak, Jessica C.G, Serné, Erik H, Groenwold, Rolf H.H, de Valk, Harold W, Kramer, Mark H.H, Nieuwdorp, Max, Verheugt, Carianne L

    Published in Diabetology and metabolic syndrome (10-10-2023)
    “…Aims The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare…”
    Get full text
    Journal Article
  12. 12

    Management of diabetes in pregnancy: Antenatal follow-up and decisions concerning timing and mode of delivery by Visser, Gerard H.A., MD, PhD, de Valk, Harold W., MD, PhD

    “…Pregnancy in women with diabetes remains complicated despite improvements in glucose control. This seems mainly due to the fact that normoglycemia is still…”
    Get full text
    Journal Article
  13. 13

    Insulin during pregnancy, labour and delivery by de Valk, Harold W., MD PhD, Visser, Gerard H.A., MD PhD

    “…Optimal glycaemic control is of the utmost importance to achieve the best possible outcome of a pregnancy complicated by diabetes. This holds for pregnancies…”
    Get full text
    Journal Article
  14. 14
  15. 15

    External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease by Smidt, Lisanne C A, Visseren, Frank L J, de Ranitz-Greven, Wendela L, Nathoe, Hendrik M, Kappelle, L Jaap, de Borst, Gert J, de Valk, Harold W, Westerink, Jan

    Published in Cardiovascular diabetology (08-09-2021)
    “…Recent treatment guidelines support the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes and cardiovascular disease…”
    Get full text
    Journal Article
  16. 16

    DPARD: rationale, design and initial results from the Dutch national diabetes registry by Bak, Jessica C G, Mul, Dick, Serné, Erik H, de Valk, Harold W, Sas, Theo C J, Geelhoed-Duijvestijn, Petronella H, Kramer, Mark H H, Nieuwdorp, Max, Verheugt, Carianne L

    Published in BMC endocrine disorders (16-06-2021)
    “…Treatment of diabetes mellitus has majorly improved over the past century, however, the disease burden is high and its prevalence still expanding. Further…”
    Get full text
    Journal Article
  17. 17

    Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients by Belle-van Meerkerk, Gerdien, MD, Cramer, Maarten J., MD, PhD, Kwakkel-van Erp, Johanna M., MD, PhD, Nugroho, Mochamed A., MD, Tahri, Sabrin, BSc, de Valk, Harold W., MD, PhD, van de Graaf, Ed A., MD, PhD

    “…Background This study investigated the prevalence of pulmonary hypertension (PH) in cystic fibrosis (CF) patients awaiting lung transplantation (LTx) and its…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients by Belle-van Meerkerk, Gerdien, de Jong, Pim A, de Valk, Harold W, Neefjes, Tim, Pameijer, Frank A, Kwakkel-van Erp, Johanna M, van de Graaf, Ed A

    Published in PloS one (23-12-2015)
    “…Peri- and postoperative complications diminish the outcome of lung transplantation (LTx) in patients with cystic fibrosis (CF). We hypothesized that the degree…”
    Get full text
    Journal Article
  20. 20

    Risk Indicators Predictive for Severe Hypoglycemia During the First Trimester of Type 1 Diabetic Pregnancy by EVERS, Inge M, TER BRAAK, Edith W. M. T, DE VALK, Harold W, VAN DER SCHOOT, Bertine, JANSSEN, Nancy, VISSER, Gerard H. A

    Published in Diabetes care (01-03-2002)
    “…Risk Indicators Predictive for Severe Hypoglycemia During the First Trimester of Type 1 Diabetic Pregnancy Inge M. Evers , MD 1 , Edith W.M.T. ter Braak , MD,…”
    Get full text
    Journal Article